NO20075727L - Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans - Google Patents

Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans

Info

Publication number
NO20075727L
NO20075727L NO20075727A NO20075727A NO20075727L NO 20075727 L NO20075727 L NO 20075727L NO 20075727 A NO20075727 A NO 20075727A NO 20075727 A NO20075727 A NO 20075727A NO 20075727 L NO20075727 L NO 20075727L
Authority
NO
Norway
Prior art keywords
subunit
adjuvant
antigen
coli heat
heat toxin
Prior art date
Application number
NO20075727A
Other languages
English (en)
Norwegian (no)
Inventor
Marianne Dewerchin
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0510280A external-priority patent/GB0510280D0/en
Priority claimed from GB0524407A external-priority patent/GB0524407D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20075727L publication Critical patent/NO20075727L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20075727A 2005-05-19 2007-11-09 Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans NO20075727L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0510280A GB0510280D0 (en) 2005-05-19 2005-05-19 Vaccines
GB0524407A GB0524407D0 (en) 2005-11-30 2005-11-30 Vaccines
PCT/GB2006/001832 WO2006123155A2 (fr) 2005-05-19 2006-05-18 Vaccins

Publications (1)

Publication Number Publication Date
NO20075727L true NO20075727L (no) 2008-02-15

Family

ID=37431620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075727A NO20075727L (no) 2005-05-19 2007-11-09 Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans

Country Status (13)

Country Link
US (1) US20090035330A1 (fr)
EP (1) EP1881844A2 (fr)
JP (1) JP2008540625A (fr)
KR (1) KR20080018201A (fr)
AU (1) AU2006248725A1 (fr)
BR (1) BRPI0610061A2 (fr)
CA (1) CA2608979A1 (fr)
EA (1) EA200702254A1 (fr)
IL (1) IL187008A0 (fr)
MA (1) MA29459B1 (fr)
MX (1) MX2007014390A (fr)
NO (1) NO20075727L (fr)
WO (1) WO2006123155A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229045A1 (fr) * 2001-02-01 2002-08-07 Institut Curie Support universel pour le ciblage de molécules sur des cellules exprimant le récepteur Gb3
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
ATE534661T1 (de) 2006-10-12 2011-12-15 Angeletti P Ist Richerche Bio Fusionsprotein aus telomerase und reverser transkriptase, dafür codierende nukleotide und anwendungen davon
EP2034022A1 (fr) 2007-09-10 2009-03-11 Universite Libre De Bruxelles Récepteur de la lipocaline soluble liant le leukotriène B4 issu de Ixodes ricinus
EP2045263A1 (fr) 2007-10-02 2009-04-08 Universite Libre De Bruxelles Identification et caractérisation moléculaire de métalloprotéases salivaires exprimées dans les glandes salivaires de la tique
WO2010144797A2 (fr) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Vaccins contre la grippe avec immunogénicité accrue et leurs utilisations
MX2011013566A (es) * 2009-06-19 2012-06-28 Eyegene Inc Vacunas para cancer cervical.
AR077636A1 (es) 2009-07-08 2011-09-14 Abbott Biologicals Bv Vacuna viral y uso de la misma
WO2015089707A1 (fr) 2013-12-16 2015-06-25 财团法人农业科技研究所 Plasmide, procédé et kit de production de sous-unité b de l'entérotoxine instable à la chaleur
KR20170040305A (ko) * 2014-08-08 2017-04-12 이데미쓰 고산 가부시키가이샤 돼지 번식·호흡 장해 증후군 방제제
US10537626B2 (en) 2014-10-07 2020-01-21 Cytlimic Inc. HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
JP6898225B2 (ja) 2015-03-09 2021-07-07 サイトリミック株式会社 Ｇｐｃ３由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
EP3797794A1 (fr) * 2015-04-07 2021-03-31 Cytlimic Inc. Médicament comprenant un agoniste au recepteur toll like 3 et une proteine lag-3
AU2017342189B2 (en) 2016-10-11 2023-09-21 Nec Corporation Medicine
CN111333734B (zh) * 2020-03-31 2022-05-03 中国人民解放军军事科学院军事医学研究院 一种百日咳丝状血凝素融合蛋白及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278302A (en) * 1988-05-26 1994-01-11 University Patents, Inc. Polynucleotide phosphorodithioates
US5843464A (en) * 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
US5666153A (en) * 1995-10-03 1997-09-09 Virtual Shopping, Inc. Retractable teleconferencing apparatus
US6764840B2 (en) * 1997-05-08 2004-07-20 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6303347B1 (en) * 1997-05-08 2001-10-16 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6558670B1 (en) * 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
CN1227030C (zh) * 1999-04-19 2005-11-16 史密丝克莱恩比彻姆生物有限公司 包含皂甙和免疫刺激寡核苷酸的佐剂组合物
GB0411411D0 (en) * 2004-05-21 2004-06-23 Glaxosmithkline Biolog Sa Vaccines

Also Published As

Publication number Publication date
MA29459B1 (fr) 2008-05-02
CA2608979A1 (fr) 2006-11-23
AU2006248725A1 (en) 2006-11-23
BRPI0610061A2 (pt) 2016-11-29
IL187008A0 (en) 2008-02-09
EP1881844A2 (fr) 2008-01-30
WO2006123155A2 (fr) 2006-11-23
US20090035330A1 (en) 2009-02-05
KR20080018201A (ko) 2008-02-27
MX2007014390A (es) 2008-02-12
EA200702254A1 (ru) 2008-06-30
WO2006123155A3 (fr) 2007-07-19
JP2008540625A (ja) 2008-11-20

Similar Documents

Publication Publication Date Title
MA29459B1 (fr) Vaccins
NZ621834A (en) Novel adjuvant compositions
WO2005112991A3 (fr) Vaccins
DK1898948T3 (da) Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
IS7593A (is) Bólusetningasamsetning sem samanstendur af transferrín bindi prótíni og HSF úr gram-neikvæðum bakteríum
EP1594536A4 (fr) Vaccin contre la grippe contenant un adjuvant
ATE491471T1 (de) Adjuvantien für dns impstoffe basierend auf imidazochinoline
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
BR0310042A (pt) Vacinas de combinação mucosal para meningite bacteriana
DK1741784T3 (da) 85kDa-antigen fra neisseria
NO20063254L (no) Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist
NO20015074D0 (no) Nye sammensetninger
DE60011560D1 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
ATE392216T1 (de) Mycobakterieller impfstoff
ITTN20020016A1 (it) Ventilconvettore ad effetto convettivo e radiante.
ATE355853T1 (de) Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine
MX2012004622A (es) Adyuvante para vacunas, vacunas que lo comprenden y usos.
WO2005013898A3 (fr) Nouvelles cibles et compositions destinees a etre utilisees dans la decontamination, l'immunoprophylaxie et le traitement post-exposition contre l'anthrax
WO2007062832A3 (fr) Vaccins
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
ZA200709633B (en) Vaccine composition comprising B-subunit of E. coli heat toxin and an antigen and an adjuvant
HK1113743A (en) Vaccine composition comprising b-subunit of e.coli heat labile toxin and an antigen and an adjuvant
WO2006095176A3 (fr) Formulation de vaccin
DK1660121T3 (da) Levende svækket bakteriel vaccine
DE69534280D1 (de) Orale impfstoffe gegen yersinia pestis infektionen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application